Although higher DSS concentrations (i.e., 0.4%/0.2%/0.4%) led to a severe outcome of colitis in Ahr-/- mice as well, here, I3C failed to improve the symptoms indicating that the therapeutic effect of I3C was AhR-dependent (Figure 2b). The gene discussed is AHR; the disease is colitis.